Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


27.11.2017

1 BJU Int
5 Bladder Cancer
1 Clin Genitourin Cancer
1 Clin Transl Oncol
1 Eur Urol Focus
1 Front Oncol
1 Genes (Basel)
1 Int J Mol Sci
4 J Cancer
1 J Immunother Cancer
2 J Urol
1 Nanotechnology
1 Neurourol Urodyn
1 Oncol Lett
1 Oncotarget
2 Urol Oncol
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BJU Int


  1. Bladder cancer: diagnosis and management of bladder cancer: (c) NICE (2015) Bladder cancer: diagnosis and management of bladder cancer.
    BJU Int. 2017;120:755-765.
    PubMed     Text format    


    Bladder Cancer

  2. MILBAR N, Kates M, Chappidi MR, Pederzoli F, et al
    Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2017;3:293-303.
    PubMed     Text format     Abstract available

  3. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Chemotherapy Versus Chemoradiation for Node-Positive Bladder Cancer: Practice Patterns and Outcomes from the National Cancer Data Base.
    Bladder Cancer. 2017;3:283-291.
    PubMed     Text format     Abstract available

  4. MALONEY I, Parker DC, Cookson MS, Patel S, et al
    Bladder Cancer Recovery Pathways: A Systematic Review.
    Bladder Cancer. 2017;3:269-281.
    PubMed     Text format     Abstract available

  5. MORAN GW, Li G, Robins DJ, Matulay JT, et al
    Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2017;3:245-258.
    PubMed     Text format     Abstract available

  6. KOTI M, Xu AS, Ren KYM, Visram K, et al
    Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer.
    Bladder Cancer. 2017;3:259-267.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  7. ZAHOOR H, Elson P, Stephenson A, Haber GP, et al
    Patient Characteristics, Treatment Patterns and Prognostic Factors in Squamous Cell Bladder Cancer.
    Clin Genitourin Cancer. 2017 Oct 17. pii: S1558-7673(17)30311.
    PubMed     Text format     Abstract available


    Clin Transl Oncol

  8. BONET M, Bonfill T, Nunez M, De Verdonces L, et al
    Curative radiation therapy for very elderly bladder cancer patients with localized disease.
    Clin Transl Oncol. 2017 Nov 20. doi: 10.1007/s12094-017-1804.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  9. DOMINGUEZ-ESCRIG JL, Peyronnet B, Seisen T, Bruins HM, et al
    Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2017 Nov 17. pii: S2405-4569(17)30236.
    PubMed     Text format     Abstract available


    Front Oncol

  10. PRASANNA T, Craft P, Balasingam G, Haxhimolla H, et al
    Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity.
    Front Oncol. 2017;7:260.
    PubMed     Text format     Abstract available


    Genes (Basel)

  11. GULIA C, Baldassarra S, Signore F, Rigon G, et al
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer.
    Genes (Basel). 2017;8.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  12. ECKE TH, Otto T
    Illumination of a Vision-How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research.
    Int J Mol Sci. 2017;18.
    PubMed     Text format     Abstract available


    J Cancer

  13. XIE H, Liao X, Chen Z, Fang Y, et al
    LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells.
    J Cancer. 2017;8:3803-3811.
    PubMed     Text format     Abstract available

  14. XU XL, Ye YL, Wu ZM, He QM, et al
    Overexpression of PTK6 predicts poor prognosis in bladder cancer patients.
    J Cancer. 2017;8:3464-3473.
    PubMed     Text format     Abstract available

  15. YANG X, Yuan W, Tao J, Li P, et al
    Identification of circular RNA signature in bladder cancer.
    J Cancer. 2017;8:3456-3463.
    PubMed     Text format     Abstract available

  16. PICHLER R, Fritz J, Heidegger I, Oberaigner W, et al
    Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy.
    J Cancer. 2017;8:3567-3574.
    PubMed     Text format     Abstract available


    J Immunother Cancer

  17. AGGEN DH, Drake CG
    Biomarkers for immunotherapy in bladder cancer: a moving target.
    J Immunother Cancer. 2017;5:94.
    PubMed     Text format     Abstract available


    J Urol

  18. CASILLA-LENNON MM, Choi SK, Deal AM, Bensen JT, et al
    Financial Toxicity in Bladder Cancer Patients- Reasons for Delay in Care and Effect on Quality of Life.
    J Urol. 2017 Nov 16. pii: S0022-5347(17)77917-7. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available

  19. KOUMPAN Y, Jaeger M, Mizubuti GB, Tanzola R, et al
    Spinal Anesthesia is Associated with Lower Recurrence Rates after Resection of Non-Muscle Invasive Bladder Cancer.
    J Urol. 2017 Nov 14. pii: S0022-5347(17)77909-8. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    Nanotechnology

  20. VIRANI NA, Davis C, McKernan P, Hauser P, et al
    Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancer.
    Nanotechnology. 2017 Nov 21. doi: 10.1088/1361-6528.
    PubMed     Text format     Abstract available


    Neurourol Urodyn

  21. ISMAIL S, Karsenty G, Chartier-Kastler E, Cussenot O, et al
    Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review.
    Neurourol Urodyn. 2017 Nov 23. doi: 10.1002/nau.23457.
    PubMed     Text format     Abstract available


    Oncol Lett

  22. GAN Y, He L, Yao K, Tan J, et al
    Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling.
    Oncol Lett. 2017;14:6463-6470.
    PubMed     Text format     Abstract available


    Oncotarget

  23. ANAN G, Hatakeyama S, Fujita N, Iwamura H, et al
    Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.
    Oncotarget. 2017;8:86130-86142.
    PubMed     Text format     Abstract available


    Urol Oncol

  24. FERGUSON JE 3RD, Kamat AM
    It's all about the perspective: Removing bias when co-managing patients with high-grade T1 bladder cancer and localized prostate cancer-A competing risks analysis.
    Urol Oncol. 2017 Nov 17. pii: S1078-1439(17)30556.
    PubMed     Text format     Abstract available

  25. SMITH AB
    Recent developments in the management of bladder cancer: Introduction.
    Urol Oncol. 2017 Nov 17. pii: S1078-1439(17)30563.
    PubMed     Text format     Abstract available


    Urology

  26. MORA VIDAL R, Regufe da Mota S, Hayden A, Markham H, et al
    EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer.
    Urology. 2017 Nov 15. pii: S0090-4295(17)31184.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: